CVS to pay $20M to settle SEC charges

(Reuters) — CVS Caremark Corp. agreed to pay $20 million to settle U.S. Securities and Exchange Commission charges that it misled investors about significant financial setbacks and used improper accounting to artificially boost its results.

The Woonsocket, R.I.-based company did not admit or deny wrongdoing in agreeing to settle.